Performance of Digital PET Compared with High-Resolution Conventional PET in Patients with Cancer.

Recently introduced PET systems using silicon photomultipliers with digital readout (dPET) have an improved timing and spatial resolution, aiming at a better image quality than conventional PET (cPET) systems. We prospectively evaluated the performance of a dPET system in patients with cancer, as compared with high-resolution (HR) cPET imaging. After a single F-FDG injection, 66 patients underwent dPET and cPET imaging in randomized order. We used HR reconstructions (2 × 2 × 2 mm voxels) for both scanners and determined SUV, SUV, lesion-to-background ratio (LBR), metabolic tumor volume (MTV), and lesion diameter in up to 5 F-FDG-positive lesions per patient. Furthermore, we counted the number of visible and measurable lesions on each PET scan. Two nuclear medicine specialists determined, in a masked manner, the TNM score from both image sets in 30 patients referred for initial staging. For all 66 patients, these specialists separately evaluated image quality (4-point scale) and determined the scan preference. We included 238 lesions that were visible and measurable on both PET scans. For 27 patients, we found 37 additional lesions on dPET (41%) that were unmeasurable ( = 14) or invisible ( = 23) on cPET. Mean (±SD) SUV, SUV LBR, and MTV on cPET were 5.2 ± 3.9, 6.9 ± 5.6, 5.0 ± 3.6, and 2,991 ± 13,251 mm, respectively. On dPET, SUV, SUV, and LBR increased by 24%, 23%, and 27%, respectively ( < 0.001) whereas MTV decreased by 13% ( < 0.001), compared with cPET. Visual analysis showed TNM upstaging with dPET in 13% of the patients (4/30). dPET images also had higher scores for quality ( = 0.003) and were visually preferred in most cases (65%). dPET improved the detection of small lesions, upstaged the disease, and produced images that were visually preferred to those from HR cPET. More studies are necessary to confirm the superior diagnostic performance of dPET. digital PET; conventional PET; FDG PET; lesion detection; cancer imaging.